KLF2 and COVID-19: Furthermore, KLF2 expression in monocytes and endothelial cells was reduced in COVID‐19 patients due to the development of endothelial dysfunction, and KLF2 activators like atorvastatin ameliorated endothelial dysfunction in COVID‐19 patients.99